Jarkova, Natalia

A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia

Kinon, B. J., Zhang, L., Millen, B. A., Osuntokun, O. O., Williams, J. E., Kollack-Walker, S., Jackson, K., Kryzhanovskaya, L., & Jarkova, N. (2011) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentNeuroscience and Neuropharmacology Research

Cited by 256

Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia

Martenyi, F., Zavadenko, N. N., Jarkova, N. B., Yarosh, A. A., Soldatenkova, V. O., Bardenstein, L. M., Kozlova, I. A., Neznanov, N. G., Maslova, O. I., Petrukhin, A. S., et al. (2010) · European Child & Adolescent Psychiatry

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 36